Abstract
10536 Background: Chemotherapy for osteosarcoma has improved the 5-year survival rate in osteosarcoma patients to 70%. However, development of new therapies for osteosarcoma is warranted, as chemot...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have